 Sponsor |  Register |
|
|
| Profile for Miljenko Zuanic |
| Add PeopleMark | Ignore Member | Send Private Message | Recent Posts |
| Posts by Miljenko Zuanic |
| Message | Subject | Recs | Date/Time (ET) |
| Because they act and live like a CAT. Can't trust them for a second! | Biotech Valuation | 08/24/2012 06:20:17 AM | |
| The question is can Trap (Zaltrap) penetrate cancer market? Sanofi was (is...?? | Regeneron Pharmaceuticals | 08/20/2012 11:41:06 AM | |
| Hi Jim, I am in Croatia, so bit slow. Eylea sales are OK (standard surprise, | Regeneron Pharmaceuticals | 1 | 07/26/2012 08:09:52 PM |
| Novartis 2Q: ..., while revenue from Lucentis jumped 12 percent to $604 million. | Regeneron Pharmaceuticals | 07/20/2012 01:40:48 AM | |
| [url=http://www.bloomberg.com/news/2012-07-19/alnylam-pharmaceuticals-in-talks-o | Regeneron Pharmaceuticals | 07/19/2012 11:52:31 PM | |
| No answer on NCE status is now possibility. | AMRN: Amarin Corporation plc | 07/13/2012 02:02:42 PM | |
| Still not clear what will be path to REGN727 approval? They are repeating HeFH t | Regeneron Pharmaceuticals | 06/16/2012 01:44:16 PM | |
| Thanks Jim. So far GLP-1 R-agonist and anti-DPP4 works in synergy with metfo | Biotech Valuation | 06/12/2012 09:15:45 PM | |
| [color=black]After success of the GLP-1 agonists, is it worth to go after GR ant | Biotech Valuation | 06/11/2012 08:59:37 PM | |
| How bad it can be? RE: BiPar Sciences PARP inhibitor and Sanofi. [url=http://w | Biotech Valuation | 06/07/2012 08:14:23 PM | |
| <<$25 target equates to about a $5b market cap.... for a so-so fish oil.>> H | Biotech Valuation | 2 | 06/07/2012 08:09:56 PM |
| OK, thanks. Need to listen presentation. | Array Pharmaceuticals ARRY | 06/07/2012 02:55:20 PM | |
| Maybe MDs do need something better than Lovaza! They need something that can dea | Biotech Valuation | 2 | 06/07/2012 02:52:29 PM |
| What next he has in sleeves? | Array Pharmaceuticals ARRY | 06/07/2012 02:23:28 PM | |
| [color=black]Slots 07/24-25 are occupied. Appears there will not be Oncology AC | Regeneron Pharmaceuticals | 06/07/2012 01:56:19 AM | |
| Sure there can be multiple player in MEK "universe". I am bit trilled that GSK i | Array Pharmaceuticals ARRY | 06/05/2012 02:56:54 AM | |
| Competitor: [url=http://www.nejm.org/doi/full/10.1056/NEJMoa1203421?query=OF]ht | Array Pharmaceuticals ARRY | 06/04/2012 08:10:18 PM | |
| ANG-2 rule? [url=http://www.jci.org/articles/view/58832]http://www.jci.org/ar | Regeneron Pharmaceuticals | 06/04/2012 07:20:06 PM | |
| July 24-25 is open slot for Oncology Drugs Advisory Committee. However, Zaltrap | Regeneron Pharmaceuticals | 05/31/2012 02:05:59 AM | |
| I am now. [color=black]After successful "Simple Retropubic Prostatectomy" fo | Biotech Valuation | 05/22/2012 08:58:18 PM | |
| So, what should we do? Do biopsy so often, or stick a finger in xxx? | Biotech Valuation | 05/21/2012 08:42:09 PM | |
| Depend how you read "invisible print" that does not show in original PR. Equ | AMRN: Amarin Corporation plc | 05/14/2012 08:25:51 PM | |
| Not clear! | AMRN: Amarin Corporation plc | 05/14/2012 01:41:02 AM | |
| Interesting development in the omega-3 business front. http://www.basf.com/g | AMRN: Amarin Corporation plc | 05/09/2012 10:43:07 PM | |
| 8-2 for safety is very good, unexpected. | Incyte Pharmaceuticals (INCY) | 05/09/2012 10:05:53 PM | |
| [color=black]Most likely Arcalyst will not be approved. It will be interesting t | Regeneron Pharmaceuticals | 05/08/2012 08:31:17 PM | |
| I was hoping for bit stronger endorsement of the efficacy with not so negative o | Regeneron Pharmaceuticals | 05/08/2012 05:20:56 PM | |
| Thanxs Jim, ...as predicted. I think that efficacy will also be seen in good l | Regeneron Pharmaceuticals | 05/08/2012 01:48:18 PM | |
| Based on quick passing over many pages, I also think that it will be "close call | Incyte Pharmaceuticals (INCY) | 05/07/2012 11:26:14 PM | |
| Did anyone review tofacitini AC briefing document? | Incyte Pharmaceuticals (INCY) | 05/07/2012 07:07:18 PM | |
| Hi Ian, Really, don't know what to tell you. This modified Resveratrol, Longe | Regeneron Pharmaceuticals | 05/06/2012 10:23:47 PM | |
| [color=black]Very entertaining presentation of CATT and IVAN. Today requiremen | Regeneron Pharmaceuticals | 05/06/2012 03:28:05 PM | |
| Small treatment effect/benefit???…I am not sure about this. Yes, absolute magnit | Regeneron Pharmaceuticals | 05/05/2012 01:25:22 AM | |
| Documents are out. Malignancy??? [url=http://www.fda.gov/AdvisoryCommittees/C | Regeneron Pharmaceuticals | 05/04/2012 10:21:17 AM | |
| http://finance.yahoo.com/news/aveo-announces-preliminary-results-exploratory-103 | AVEO Pharmaceuticals | 05/02/2012 07:40:27 PM | |
| Results are out, [url=http://www.uphs.upenn.edu/news/News_Releases/2012/04/visi | Regeneron Pharmaceuticals | 04/30/2012 08:45:28 PM | |
| Tuck, Any update on your search regards syk inhibitor landscape (competitors | Rigel Pharmaceuticals, Inc. (RIGL) | 04/27/2012 10:24:09 PM | |
| Hi Rick, how is life treating you these days? Proverb (originated i | Regeneron Pharmaceuticals | 04/26/2012 03:44:47 PM | |
| [color=black]Very good CC, I like the optimism on Arcalyst and 475. I continue t | Regeneron Pharmaceuticals | 04/26/2012 09:18:57 AM | |
| WOW! | Regeneron Pharmaceuticals | 04/26/2012 08:33:39 AM | |
| [color=black]Any number around 80M (+/- 5%) is a good one. It will be an interes | Regeneron Pharmaceuticals | 04/25/2012 09:37:09 PM | |
| Maybe good! What do you expect? $80M in Eylea sale? Less, more? | Regeneron Pharmaceuticals | 04/24/2012 05:58:06 PM | |
| CATT live: [url=http://prolibraries.com/arvo/registration/event]http://prolib | Regeneron Pharmaceuticals | 04/18/2012 10:17:07 PM | |
| AD, cardiotoxicity is documented for ALL targeted drug for RCC. | AVEO Pharmaceuticals | 04/18/2012 09:26:27 PM | |
| Peter, “all we know about the Phase III was that safety was consistent with the | AVEO Pharmaceuticals | 04/18/2012 09:23:22 PM | |
| OT Reply at [url=http://www.siliconinvestor.com/subject.aspx?subjectid=58683]h | Biotech Valuation | 04/18/2012 02:39:00 PM | |
| OT (going forward posts will be on AVEO site) [b] [/b] Non-toxicity is | Biotech Valuation | 04/17/2012 11:12:58 PM | |
| Thanks Peter, I done bit of search on AV-591 (currently do not have time fo | Biotech Valuation | 04/16/2012 08:54:21 PM | |
| An interesting play for ASCO and beyond. Was there any OS benefit in RCC (reg | Biotech Valuation | 04/15/2012 12:19:47 PM | |
| I never liked sucker (AF), so if this put him into "trouble spot", so be it. | VVUS: VIVUS INC. (NASDAQ) | 04/11/2012 08:29:39 PM |
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ |
